EMEA-001006-PIP05-18-M01

Key facts

Invented name
  • Ofev
  • Vargatef
Active substance
nintedanib
Therapeutic area
  • Oncology
  • Pneumology-allergology
Decision number
P/0438/2021
PIP number
EMEA-001006-PIP05-18-M01
Pharmaceutical form(s)
Capsule, soft
Condition(s) / indication(s)
Treatment of fibrosing Interstitial Lung Diseases (ILD)
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

E-mail: COMMSPaediatrics@boehringer-ingelheim.com
Tel: +49 (0)6132 77 8271

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating